Neonatology · 2025
Treatment with Plasma Transfusion and Plasma-Derived Human Plasminogen in a Newborn with Plasminogen Deficiency and Recurrent Hydrocephalus: A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iovannitti Giorgia, Bianchi Federico, Massimi Luca, Frassanito Paolo, Tamburrini Gianpiero
Аннотация
INTRODUCTION: Plasminogen deficiency is a congenital autosomal recessive disorder. Ligneous conjunctivitis is pathognomonic for the disease; however, hydrocephalus is a rare complication.
CASE PRESENTATION: A neonate with prenatal diagnosis of hydrocephalus associated with Dandy-Walker syndrome was sent to our observation. Surgery was followed by multiple shunt malfunctions in the early postoperative period. An ophthalmological evaluation suggested the diagnosis of ligneous conjunctivitis. Laboratory tests lead to the diagnosis of a systemic PLGD. The disease caused the formation of multiple membranes, which prevented the proper functioning of the ventricular shunts. We started an alternated treatment with plasma transfusions and plasma-derived human plasminogen. This has allowed the control of the complications related to the treatment of the hydrocephalus.
DISCUSSION: Ligneous conjunctivitis was pivotal in the diagnosis of pathology. It is currently difficult to get sufficient doses of plasma-derived human plasminogen for ev administration, considering that it is still not officially authorized in Europe.
CASE PRESENTATION: A neonate with prenatal diagnosis of hydrocephalus associated with Dandy-Walker syndrome was sent to our observation. Surgery was followed by multiple shunt malfunctions in the early postoperative period. An ophthalmological evaluation suggested the diagnosis of ligneous conjunctivitis. Laboratory tests lead to the diagnosis of a systemic PLGD. The disease caused the formation of multiple membranes, which prevented the proper functioning of the ventricular shunts. We started an alternated treatment with plasma transfusions and plasma-derived human plasminogen. This has allowed the control of the complications related to the treatment of the hydrocephalus.
DISCUSSION: Ligneous conjunctivitis was pivotal in the diagnosis of pathology. It is currently difficult to get sufficient doses of plasma-derived human plasminogen for ev administration, considering that it is still not officially authorized in Europe.